Three-part CME Series: Allogeneic Transplantation: Applying New Research for Improved Outcomes

This series is jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC and is supported by an educational grant from the National Marrow Donor Program.

Access all three online CME programs:

Allogeneic Transplantation: Applying New Research for Improved Outcomes

Description

Whether you treat patients with transplantable disorders or perform hematopoietic transplantation, these CME-certified programs provide an efficient way to hear the latest review in allogeneic transplantation today. Includes: when transplant should be considered, which factors influence outcomes, the effect of age on patient eligibility and recent advances in HLA matching.

Access individual programs:

Series Part 1:
Comparing Outcomes of Related and Unrelated Transplantation

Claudio Anasetti, M.D.
Moffitt Cancer Center and Research Institute
Tampa, Florida

Series Part 2:
Transplantation from Unrelated Donors: Factors That Influence Outcomes and Graft Choices

Mary M. Horowitz, M.D., M.S.
Medical College of Wisconsin
Milwaukee, Wisconsin

Series Part 3:
Advances in HLA Matching for Unrelated Donor Transplantation

Dennis L. Confer, M.D.
National Marrow Donor Program
Minneapolis, Minnesota

Questions

If you have any questions regarding this program, call Renee Ryan at (800) 526-7809 ext. 8430, or e-mail rryan@nmdp.org